My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Biotech and Pharmaceuticals Viking Therapeutics Inc Altimmune Inc
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Health & Science Eisai Co Ltd Companies
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Eli Lilly and Co Biotech and Pharmaceuticals Roche Holding AG
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Science Biotechnology Business
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags US: News Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell
Tags Tesla Inc Amazon/com Inc Business News
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags Taiwan Semiconductor Manufacturing Co Ltd Obesity Artificial intelligence
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags Market Outlook Semiconductor device manufacturing Daily Open
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Zealand Pharma A/S Business News Business
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Biotech and Pharmaceuticals Healthy Returns Eli Lilly and Co
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Eli Lilly and Co Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Companies Health & Science Health care industry
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Business News Novo Nordisk A/S Business
From CNBC.com News
Jim Cramer reviews 8 companies that could top $1 trillion in market cap
Tags Alphabet Inc Business Eli Lilly and Co
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags UnitedHealth Group Inc Health care industry Health & Science
From CNBC.com News
Companies besides tech can reach megacap status, Jim Cramer says
Tags U/S/ Markets Mad Money Microsoft Corp
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Health care industry Prescription drugs Wall Street
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags CVS Health Corp Gilead Sciences Inc Eli Lilly and Co
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Technology Oil and Gas Daily Open
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Paramount Global Nasdaq Inc Eli Lilly and Co
From CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
Tags US: News Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
Tags Amgen Inc Alnylam Pharmaceuticals Inc US: News
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Eli Lilly and Co Gilead Sciences Inc Health & Science
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
Tags Business News Business Chewy Inc
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags US Top News and Analysis Biotechnology Business
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Health & Science Companies Health care industry
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Health care industry Health & Science Companies
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Breaking News: Markets Novo Nordisk A/S Zealand Pharma A/S
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Biotech and Pharmaceuticals Social issues Eli Lilly and Co
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags CNBC Changemakers Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.